Last Updated on October 10, 2025 by The Health Master
Stickers on Medicines
Ever notice those pricing labels and stickers on medicines? While they may seem unnecessary, they’re an integral part of the government’s price management system.
But soon, it’ll all get a lot clearer and less expensive for us all!
The Indian government has officially announced a reduction in taxes on drugs and medical devices, meaning the prices will come down for you!
And to ensure a swift transition, the government’s Central Drugs Standard Control Organisation (CDSCO) is connecting with manufacturers to apply new price stickers on medicines and medical devices.
This is an important initiative because it implies that the benefit of the new reduced Goods and Services Tax (GST) will actually trickle down to the end consumer instead of just remaining with the manufacturers.
A move to make medicine cheaper
The CDSCO has issued a communication to all state and central drug authorities asking them to fast track something called “no objection” approvals.
Manufacturers require a no-objection approval process to enact label changes pertaining to their products, and inclusion of revised pricing is part of this.
In simple terms, if a manufacturer produces thousands of bottles of a specific drug but already packaged them with the older pricing, to avoid wastage and losing business, they’ll essentially slap a new sticker on the bottle indicating the new price.
Fast-tracking such approvals will reduce the time taken for consumers to benefit from reduced pricing.
Special circumstances for Medical Devices
Drugs aren’t the only products benefiting from price cuts.
Many medical devices are also experiencing changes in pricing.
In fact, for select important devices, the government has an exclusive allowance.
For more important medical devices (like blood glucose monitors), known as Class C and Class D medical devices, the manufacturers have three months’ time to update their prices via stickers.
- Class A & B medical devices: These are low-risk medical devices; their pricing adjustments will be applied by the state authority.
- Class C & D medical devices: These are more complicated and critical medical devices; these FDA approvals will be governed by a central authority.
Thus, all medical equipment gets a price adjustment with relative ease.
The big deal: Why this is happening now
So why are these price changes being implemented now? It’s all thanks to the GST Council, a committee focused on tax rate assessment that recently convened and proposed some drastic recommendations that benefit us all.
- GST imposed on all drugs and medical devices reduced: The tax has been reduced to 5%!
- GST waived on life-saving drugs: For 36 life-saving drugs, no taxation will be applied.
- Lower tax on varied medical apparatus: Items like surgical implements and diagnostic kits were reduced from 18% to 5% and 12% to 5%, respectively.
This is great news for families who need access to these important health products because it makes them more affordable and accessible.
What’s next?
While this is all great news, the industry is concerned about logistics.
How can one effectively sticker-relabel millions of products in a short time frame?
The worry is valid.
Yet government officials have long been in contact with manufacturers to ensure no disruption occurs.
Keep in mind, the availability of these medications and supplies should remain standard so that you receive them as you always have.
Q: Which medical devices are included in the price change?
A: GST rates have been slashed across the board for a variety of medical devices ranging from surgical instruments, kits, and diagnostic implements to glucometers and blood glucose monitoring systems. Both simple and critical medical devices qualify under this umbrella.
Q: When do these changes take effect?
A: The new changes are effective immediately as of September 22, 2025. Meaning you’ll soon see the lowered prices on medical devices and medications.
Disclaimer: This article contains information obtained from the source mentioned below. Our team made changes in the format to rewrite and present the news or article in a unique format.
GST Penalty of Rs. 1.11 Crore on Cipla
Aurobindo Pharma Faces Rs 11 Crore GST Demand
DPCO 2013: Form 2, 4 & 5 amended to add details including GST rate
Braille labeling on Medicine Strips: A New Era
USFDA puts import Alert on Sun Pharma: Halol
Indian Drug Regulation Goes 97% Digital: CDSCO
5 Northern State SDCs Unite Against Counterfeit Drugs
USFDA issued Form 483 to Biocon with 5 observations
USFDA issued Form 483 to Aurobindo with 8 observations
Drug recall: Unichem recalls Cyclobenzaprine HCL Tablets
Govt. amends Uniform Code for Marketing Medical Devices
